tradingkey.logo

Sonnet Biotherapeutics Holdings Inc <SONN.OQ> expected to post a loss of $1.39 a share - Earnings Preview

ReutersFeb 10, 2025 1:40 PM
  • Sonnet Biotherapeutics Holdings Inc SONN.OQ SONN.O is expected to show a fall in quarterly revenue when it reports results on February 12 (estimated) for the period ending December 31 2024

  • ​LSEG's mean analyst estimate for Sonnet Biotherapeutics Holdings Inc is for a loss of $1.39 per share.

  • The one available analyst rating on the shares is "buy".

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Sonnet Biotherapeutics Holdings Inc is $20.00​, above​ its last closing price of $1.59. ​​​

This summary was machine generated February 10 at 13:40 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI